annual CAPEX:
$1.35M+$746.00K(+122.50%)Summary
- As of today (July 1, 2025), PTGX annual capital expenditures is $1.35 million, with the most recent change of +$746.00 thousand (+122.50%) on December 31, 2024.
- During the last 3 years, PTGX annual CAPEX has risen by +$254.00 thousand (+23.07%).
- PTGX annual CAPEX is now at all-time high.
Performance
PTGX CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly CAPEX:
$545.00K+$235.00K(+75.81%)Summary
- As of today (July 1, 2025), PTGX quarterly capital expenditures is $545.00 thousand, with the most recent change of +$235.00 thousand (+75.81%) on March 1, 2025.
- Over the past year, PTGX quarterly CAPEX has increased by +$303.00 thousand (+125.21%).
- PTGX quarterly CAPEX is now -38.90% below its all-time high of $892.00 thousand, reached on June 30, 2019.
Performance
PTGX quarterly CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM CAPEX:
$1.66M+$303.00K(+22.36%)Summary
- As of today (July 1, 2025), PTGX TTM capital expenditures is $1.66 million, with the most recent change of +$303.00 thousand (+22.36%) on March 1, 2025.
- Over the past year, PTGX TTM CAPEX has increased by +$817.00 thousand (+97.15%).
- PTGX TTM CAPEX is now at all-time high.
Performance
PTGX TTM CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
PTGX CAPEX Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | +122.5% | +125.2% | +97.2% |
3 y3 years | +23.1% | +99.6% | +34.4% |
5 y5 years | +40.1% | +294.9% | +821.1% |
PTGX CAPEX Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3-year | at high | +122.5% | -29.7% | +5350.0% | at high | +296.6% |
5 y | 5-year | at high | +187.7% | -29.7% | +5350.0% | at high | +821.1% |
alltime | all time | at high | +187.7% | -38.9% | +276.4% | at high | +821.1% |
PTGX CAPEX History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Mar 2025 | - | $545.00K(+75.8%) | $1.66M(+22.4%) |
Dec 2024 | $1.35M(+122.5%) | $310.00K(-60.0%) | $1.35M(+27.3%) |
Sep 2024 | - | $775.00K(+2667.9%) | $1.06M(+53.5%) |
Jun 2024 | - | $28.00K(-88.4%) | $693.00K(-17.6%) |
Mar 2024 | - | $242.00K(+1173.7%) | $841.00K(+38.1%) |
Dec 2023 | $609.00K(-23.4%) | $19.00K(-95.3%) | $609.00K(-7.7%) |
Sep 2023 | - | $404.00K(+129.5%) | $660.00K(+57.9%) |
Jun 2023 | - | $176.00K(+1660.0%) | $418.00K(-21.4%) |
Mar 2023 | - | $10.00K(-85.7%) | $532.00K(-33.1%) |
Dec 2022 | $795.00K(-27.8%) | $70.00K(-56.8%) | $795.00K(-13.7%) |
Sep 2022 | - | $162.00K(-44.1%) | $921.00K(-10.1%) |
Jun 2022 | - | $290.00K(+6.2%) | $1.02M(-17.0%) |
Mar 2022 | - | $273.00K(+39.3%) | $1.23M(+12.1%) |
Dec 2021 | $1.10M | $196.00K(-26.0%) | $1.10M(+6.9%) |
Sep 2021 | - | $265.00K(-47.0%) | $1.03M(+22.6%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Jun 2021 | - | $500.00K(+257.1%) | $840.00K(+77.6%) |
Mar 2021 | - | $140.00K(+12.0%) | $473.00K(+0.4%) |
Dec 2020 | $471.00K(-51.3%) | $125.00K(+66.7%) | $471.00K(-16.5%) |
Sep 2020 | - | $75.00K(-43.6%) | $564.00K(+213.3%) |
Jun 2020 | - | $133.00K(-3.6%) | $180.00K(-80.8%) |
Mar 2020 | - | $138.00K(-36.7%) | $939.00K(-2.9%) |
Dec 2019 | $967.00K(+99.0%) | $218.00K(-170.6%) | $967.00K(+19.2%) |
Sep 2019 | - | -$309.00K(-134.6%) | $811.00K(-36.0%) |
Jun 2019 | - | $892.00K(+437.3%) | $1.27M(+185.6%) |
Mar 2019 | - | $166.00K(+167.7%) | $444.00K(-8.6%) |
Dec 2018 | $486.00K(-27.0%) | $62.00K(-58.1%) | $486.00K(+1.3%) |
Sep 2018 | - | $148.00K(+117.6%) | $480.00K(-8.0%) |
Jun 2018 | - | $68.00K(-67.3%) | $522.00K(+15.0%) |
Mar 2018 | - | $208.00K(+271.4%) | $454.00K(+84.6%) |
Dec 2017 | $666.00K | $56.00K(-70.5%) | $246.00K(+29.5%) |
Sep 2017 | - | $190.00K | $190.00K |
FAQ
- What is Protagonist Therapeutics annual capital expenditures?
- What is the all time high annual CAPEX for Protagonist Therapeutics?
- What is Protagonist Therapeutics annual CAPEX year-on-year change?
- What is Protagonist Therapeutics quarterly capital expenditures?
- What is the all time high quarterly CAPEX for Protagonist Therapeutics?
- What is Protagonist Therapeutics quarterly CAPEX year-on-year change?
- What is Protagonist Therapeutics TTM capital expenditures?
- What is the all time high TTM CAPEX for Protagonist Therapeutics?
- What is Protagonist Therapeutics TTM CAPEX year-on-year change?
What is Protagonist Therapeutics annual capital expenditures?
The current annual CAPEX of PTGX is $1.35M
What is the all time high annual CAPEX for Protagonist Therapeutics?
Protagonist Therapeutics all-time high annual capital expenditures is $1.35M
What is Protagonist Therapeutics annual CAPEX year-on-year change?
Over the past year, PTGX annual capital expenditures has changed by +$746.00K (+122.50%)
What is Protagonist Therapeutics quarterly capital expenditures?
The current quarterly CAPEX of PTGX is $545.00K
What is the all time high quarterly CAPEX for Protagonist Therapeutics?
Protagonist Therapeutics all-time high quarterly capital expenditures is $892.00K
What is Protagonist Therapeutics quarterly CAPEX year-on-year change?
Over the past year, PTGX quarterly capital expenditures has changed by +$303.00K (+125.21%)
What is Protagonist Therapeutics TTM capital expenditures?
The current TTM CAPEX of PTGX is $1.66M
What is the all time high TTM CAPEX for Protagonist Therapeutics?
Protagonist Therapeutics all-time high TTM capital expenditures is $1.66M
What is Protagonist Therapeutics TTM CAPEX year-on-year change?
Over the past year, PTGX TTM capital expenditures has changed by +$817.00K (+97.15%)